Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence

The current classification of ductal carcinoma in situ (DCIS) is based on nuclear grade, architectural differentiation and the presence of necrosis that does not adequately predict the likelihood of recurrence after breast conserving therapy; therefore, there is a critical need to identify novel pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Witkiewicz, Agnieszka K, Freydin, Boris, Chervoneva, Inna, Potoczek, Magdalena, Rizzo, Wendy, Rui, Hallgeir, Brody, Jonathan R, Schwartz, Gordon F, Lisanti, Michael P
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2010
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3040854/
https://ncbi.nlm.nih.gov/pubmed/20574156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.10.4.12449
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars